Home » Med-tech diagnostics with U.S. FDA emergency use authorization for COVID-19

Med-tech diagnostics with U.S. FDA emergency use authorization for COVID-19

*This chart includes COVID-19 diagnostics featured in BioWorld MedTech. It was updated through March 2021. For more details about COVID-19 therapeutics and vaccines, diagnostics and clinical trial delays, go to BioWorld Snapshots.

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Med-tech diagnostics with U.S. FDA emergency use authorization for COVID-19

Today's news in brief

Today's news in brief

Enhanced Cognition: Lewy body dementia phase II pumps stock

Second insulin receptor offers new therapeutic avenues

Experimental mRNA gene therapy suppresses preeclampsia in mice